COVID-19: Household Exposure Study



COVID-19 CLINICAL TRIAL FOR

HOUSEHOLD EXPOSURE TO COVID-19

Monoclonal Antibody Therapy by REGENERON

This study is for individuals that live in same household as someone who is infected with COVID-19 to prevent infection. In addition, the study is single injection of monoclonal antibody (2 doses) vs Placebo as investigation treatment.

Summary Inclusions for the study are:

  • Age 18 years and over
  • Asymptomatic household contact to an individual with COVID-19 who was diagnosed in the past 96 hours (4 days)
  • Willing and able to comply with study visits and study-related procedures/assessments
  • Able to consent

Summary Exclusions for the study are:

  • Prior positive COVID-19 test
  • Active respiratory or non-respiratory symptoms consistent with COVID-19
  • No current hospitalization or recently hospitalized (within 30 days)
  • Pregnant/breastfeeding


Sign-up to enroll for this study today!








    Social networks


    Facebook

    www.facebook.com/azclinicaltrials


    Twitter

    @azclintrials


    Instagram

    @azclinicaltrials



    Locations


    Mesa Office

    2152 S Vineyard Ave Ste 123
    Mesa, AZ 85210
    480-360-4000


    Tucson Office

    1601 N Swan Rd
    Tucson, AZ 85712
    520-445-4000


    Call us to see if you or your patient qualify for a clinical trial.